Cystic Fibrosis is a existence-decreasing genetic disorder and whereas outcomes receive improved, half of of these with it gain no longer live past 40.
Orkambi is a drug that targets a mutation that spherical 50% of of us with cystic fibrosis in the UK receive. It has been shown to enhance lung health by as a lot as 42%.
Licensed for utilize in the UK since 2015, it prices spherical £105,000 per patient per twelve months so is no longer readily accessible on the NHS, excluding for obvious of us on compassionate grounds.
Leave a comment
Sign in to post your comment or sign-up if you don't have any account.